7月內地有127款國產及7款進口網絡遊戲獲批 百度及網易等在列
國家新聞出版署公佈7月國產網絡遊戲審批訊息顯示,共有127款遊戲獲批,包括百度-SW(09888.HK)(BIDU.US)關聯公司北京百度多酷科技多酷科技的《玄女戰紀》和《徵戰祕境》、愷英網絡(002517.SZ)的《荒野守則》、巨人網絡(002558.SZ)的《名將殺》及冰川網絡(300533.SZ)的《奇?建造師》等遊戲在列。
公告並顯示,7月共有7款進口遊戲獲批,包括網易-S(09999.HK)(NTES.US)旗下上海網之易網絡科技發展的《暗黑破壞神IV》在列。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.